170 related articles for article (PubMed ID: 31903852)
1. Identification of a novel binding mechanism of Quinoline based molecules with lactate dehydrogenase of
Singh R; Bhardwaj V; Purohit R
J Biomol Struct Dyn; 2021 Jan; 39(1):348-356. PubMed ID: 31903852
[TBL] [Abstract][Full Text] [Related]
2. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
[TBL] [Abstract][Full Text] [Related]
3. Highly potent anti-malarial activity of benzopyrano(4,3-b)benzopyran derivatives and
Joshi N; Hada R; Gupta S; Khan J; Dobrowolski J; Dhar PK; Kumar N; Singh S
J Biomol Struct Dyn; 2022 Jul; 40(11):5159-5174. PubMed ID: 33416018
[TBL] [Abstract][Full Text] [Related]
4. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
5. An Allosteric Inhibitory Potential of Triterpenes from Combretum racemosum on the Structural and Functional Dynamics of Plasmodium falciparum Lactate Dehydrogenase Binding Landscape.
Oluyemi WM; Samuel BB; Adewumi AT; Adekunle YA; Soliman MES; Krenn L
Chem Biodivers; 2022 Feb; 19(2):e202100646. PubMed ID: 34982514
[TBL] [Abstract][Full Text] [Related]
6. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
Penna-Coutinho J; Cortopassi WA; Oliveira AA; França TC; Krettli AU
PLoS One; 2011; 6(7):e21237. PubMed ID: 21779323
[TBL] [Abstract][Full Text] [Related]
8. A novel quinoline-appended chalcone derivative as potential
Kumar H; Wadi I; Devaraji V; Pillai CR; Ghosh SK
J Vector Borne Dis; 2019; 56(3):189-199. PubMed ID: 32655067
[TBL] [Abstract][Full Text] [Related]
9. A profound computational study to prioritize the natural compound inhibitors against the
Manhas A; Dubey S; Jha PC
J Biomol Struct Dyn; 2020 Jun; 38(9):2704-2716. PubMed ID: 31304874
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.
Choi SR; Pradhan A; Hammond NL; Chittiboyina AG; Tekwani BL; Avery MA
J Med Chem; 2007 Aug; 50(16):3841-50. PubMed ID: 17636950
[TBL] [Abstract][Full Text] [Related]
11. Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.
Choi SR; Beeler AB; Pradhan A; Watkins EB; Rimoldi JM; Tekwani B; Avery MA
J Comb Chem; 2007; 9(2):292-300. PubMed ID: 17316052
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study.
Kumar R; Sharma R; Kumar I; Upadhyay P; Dhiman AK; Kumar R; Kumar R; Purohit R; Sahal D; Sharma U
Med Chem; 2019; 15(7):790-800. PubMed ID: 30324888
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity of Plasmodium vivax and Plasmodium falciparum lactate dehydrogenases in Myanmar isolates.
Lee J; Kim TI; Lê HG; Yoo WG; Kang JM; Ahn SK; Myint MK; Lin K; Kim TS; Na BK
Malar J; 2020 Feb; 19(1):60. PubMed ID: 32019541
[TBL] [Abstract][Full Text] [Related]
14. The antimalarial drug, chloroquine, interacts with lactate dehydrogenase from Plasmodium falciparum.
Menting JG; Tilley L; Deady LW; Ng K; Simpson RJ; Cowman AF; Foley M
Mol Biochem Parasitol; 1997 Sep; 88(1-2):215-24. PubMed ID: 9274881
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vivo anti-malarial investigation on 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine derivatives.
Tahghighi A; Mohamadi-Zarch SM; Rahimi H; Marashiyan M; Maleki-Ravasan N; Eslamifar A
Malar J; 2020 Jun; 19(1):231. PubMed ID: 32600425
[TBL] [Abstract][Full Text] [Related]
16. In Silico Screening and Molecular Dynamics Simulation of Potential Anti-Malarial Agents from
Heikal MF; Putra WE; Sustiprijatno ; Rifa'i M; Hidayatullah A; Ningsih FN; Widiastuti D; Shuib AS; Zulfiani BF; Hanasepti AF
Trop Life Sci Res; 2023 Jun; 34(2):1-20. PubMed ID: 38144376
[TBL] [Abstract][Full Text] [Related]
17. Targeting metacaspase-3 from
Kumar B; Mohammad T; Amaduddin ; Hussain A; Islam A; Ahmad F; Alajmi MF; Singh S; Pandey KC; Hassan MI; Abid M
J Biomol Struct Dyn; 2021 Feb; 39(2):421-430. PubMed ID: 31900062
[TBL] [Abstract][Full Text] [Related]
18. Design of novel dihydroxynaphthoic acid inhibitors of Plasmodium falciparum lactate dehydrogenase.
Megnassan E; Keita M; Bieri C; Esmel A; Frecer V; Miertus S
Med Chem; 2012 Sep; 8(5):970-84. PubMed ID: 22741776
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase.
Vivas L; Easton A; Kendrick H; Cameron A; Lavandera JL; Barros D; de las Heras FG; Brady RL; Croft SL
Exp Parasitol; 2005 Oct; 111(2):105-14. PubMed ID: 16098967
[TBL] [Abstract][Full Text] [Related]
20. Pyrazole based Furanone Hybrids as Novel Antimalarial: A Combined Experimental, Pharmacological and Computational Study.
Choudhary D; Rani I; Monga J; Goyal R; Husain A; Garg P; Khokra SL
Cent Nerv Syst Agents Med Chem; 2022; 22(1):39-56. PubMed ID: 35232355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
